Endothelial dysfunction induces atherosclerosis: increased aggrecan expression promotes apoptosis in vascular smooth muscle cells |
Kim, Sang-Min
(Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine)
Huh, Jae-Wan (Department of Biochemistry and Molecular Biology, Asan Medical Center, University of Ulsan College of Medicine) Kim, Eun-Young (Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine) Shin, Min-Kyung (Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine) Park, Ji-Eun (Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine) Kim, Seong Who (Department of Biochemistry and Molecular Biology, Asan Medical Center, University of Ulsan College of Medicine) Lee, Wooseong (Department of Biochemistry and Molecular Biology, Asan Medical Center, University of Ulsan College of Medicine) Choi, Bongkun (Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine) Chang, Eun-Ju (Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine) |
1 | Furchgott RF and Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376 DOI |
2 | Davignon J and Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109, III27-32 |
3 | Mooradian DL, Hutsell TC and Keefer LK (1995) Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol 25, 674-678 DOI |
4 | Ponnuswamy P, Schrottle A, Ostermeier E et al (2012) eNOS protects from atherosclerosis despite relevant superoxide production by the enzyme in apoE mice. PLoS One 7, e30193 DOI |
5 | Flammer AJ, Anderson T, Celermajer DS et al (2012) The assessment of endothelial function: from research into clinical practice. Circulation 126, 753-767 DOI |
6 | Bogaty P, Hackett D, Davies G and Maseri A (1994) Vasoreactivity of the culprit lesion in unstable angina. Circulation 90, 5-11 DOI |
7 | Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA and Billingham ME (1992) Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 90, 1168-1172 DOI |
8 | Lusis AJ (2000) Atherosclerosis. Nature 407, 233-241 DOI |
9 | Libby P, Ridker PM and Hansson GK (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473, 317-325 DOI |
10 | Clarke MC, Figg N, Maguire JJ et al (2006) Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 12, 1075-1080 DOI |
11 | Klouche M, Peri G, Knabbe C et al (2004) Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells. Atherosclerosis 175, 221-228 DOI |
12 | Zhang MJ, Zhou Y, Chen L et al (2016) Impaired SIRT1 promotes the migration of vascular smooth muscle cell-derived foam cells. Histochem Cell Biol 146, 33-43 DOI |
13 | Kockx MM and Herman AG (2000) Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res 45, 736-746 DOI |
14 | Martinet W and Kockx MM (2001) Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation. Curr Opin Lipidol 12, 535-541 DOI |
15 | Martinet W and De Meyer GR (2009) Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ Res 104, 304-317 DOI |
16 | Littlewood TD and Bennett MR (2003) Apoptotic cell death in atherosclerosis. Curr Opin Lipidol 14, 469-475 DOI |
17 | Kuhlencordt PJ, Gyurko R, Han F et al (2001) Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104, 448-454 DOI |
18 | Cao L and Yang BB (1999) Chondrocyte apoptosis induced by aggrecan G1 domain as a result of decreased cell adhesion. Exp Cell Res 246, 527-537 DOI |
19 | Strom A, Ahlqvist E, Franzen A, Heinegard D and Hultgardh-Nilsson A (2004) Extracellular matrix components in atherosclerotic arteries of Apo E/LDL receptor deficient mice: an immunohistochemical study. Histol Histopathol 19, 337-347 |
20 | Talusan P, Bedri S, Yang S et al (2005) Analysis of intimal proteoglycans in atherosclerosis-prone and atherosclerosisresistant human arteries by mass spectrometry. Mol Cell Proteomics 4, 1350-1357 DOI |
21 | Fujimoto T, Kawashima H, Tanaka T et al (2001) CD44 binds a chondroitin sulfate proteoglycan, aggrecan. Int Immunol 13, 359-366 DOI |
22 | Gentleman RC, Carey VJ, Bates DM et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5, R80 DOI |
23 | Didangelos A, Mayr U, Monaco C and Mayr M (2012) Novel role of ADAMTS-5 protein in proteoglycan turnover and lipoprotein retention in atherosclerosis. J Biol Chem 287, 19341-19345 DOI |
24 | Stevens AL, Wheeler CA, Tannenbaum SR and Grodzinsky AJ (2008) Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants. Osteoarthritis Cartilage 16, 489-497 DOI |
25 | Ross R, Glomset J, Kariya B and Harker L (1974) A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A 71, 1207-1210 DOI |